ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $966,063 | +193.6% | 47,148 | +184.7% | 0.00% | +100.0% |
Q2 2023 | $329,067 | +37.8% | 16,561 | +35.7% | 0.00% | 0.0% |
Q4 2022 | $238,774 | -37.3% | 12,201 | -48.9% | 0.00% | -50.0% |
Q3 2022 | $381,000 | -14.4% | 23,875 | -14.9% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -51.2% | 28,056 | -32.8% | 0.00% | 0.0% |
Q4 2021 | $912,000 | +8.6% | 41,771 | +120.7% | 0.00% | -60.0% |
Q1 2021 | $840,000 | -27.1% | 18,923 | -9.9% | 0.01% | -44.4% |
Q4 2020 | $1,152,000 | +53.2% | 21,010 | -36.1% | 0.01% | -10.0% |
Q3 2020 | $752,000 | -37.7% | 32,888 | -43.0% | 0.01% | -50.0% |
Q2 2020 | $1,208,000 | +175.8% | 57,715 | +199.6% | 0.02% | +566.7% |
Q4 2019 | $438,000 | +8.7% | 19,262 | -44.3% | 0.00% | -25.0% |
Q3 2019 | $403,000 | -30.9% | 34,578 | -11.0% | 0.00% | -33.3% |
Q2 2019 | $583,000 | -1.9% | 38,864 | +14.8% | 0.01% | 0.0% |
Q1 2019 | $594,000 | -15.5% | 33,856 | -28.6% | 0.01% | -25.0% |
Q4 2018 | $703,000 | +154.7% | 47,419 | +323.4% | 0.01% | +166.7% |
Q3 2018 | $276,000 | – | 11,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |